Blood test to study cancer changes during first treatment
Part of Cancer, Lungs & breathing clinical trials.
This study looks at how small cell lung cancer changes over time by testing your blood during your first treatment. They will collect blood samples to see if certain patterns can help predict how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of small cell lung cancer (SCLC).
- You must be starting your first treatment, which will be a combination of chemotherapy and immunotherapy (called chemo-immunotherapy).
- You must be 18 years or older.
- You must be able to understand French and be enrolled in the French social security system.
- You must receive your care at Cochin Hospital or HEGP in Paris.
- You must be willing to provide blood samples for this research study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects blood and tumor samples from people newly diagnosed with small cell lung cancer to study how genetic markers can predict treatment success and monitor disease over time.
This observational study collects information and lab samples from people with extensive-stage small cell lung cancer. It may help researchers understand how patients respond and improve future care, but it usually does not add new treatment for you.
This study looks at immune-related blood/tissue markers to understand disease activity in people with extensive-stage small cell lung cancer after standard upfront treatment. If your cancer fits the pattern they’re studying, it may help researchers improve how future treatments are matched to patients.
This study collects tissue (and follows patients over time) to better understand the natural course of several types of chest cancers. It may help researchers learn which tests and treatments work best in different cancer types.
This trial tests a new study drug (PF08634404) combined with standard chemotherapy for people whose non-small cell lung cancer has changed into a more aggressive form called small cell lung cancer. It hopes to improve outcomes by targeting the cancer in two ways.
This trial is for people with advanced non-small cell lung cancer (NSCLC) who have not yet started treatment. It studies a simple blood test that checks for genetic changes in the cancer, to help doctors choose the most effective first treatment.
Hear when a new Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.